Distinct pathways for genetic and epigenetic predisposition in familial and bilateral Wilms tumor

We identified two main mechanisms of Wilms tumor predisposition: either germline genetic alterations of Wilms tumor and, less frequently, general cancer genes; or postzygotic mosaic imprinting defects activating IGF2. These findings inform future genetic screening and risk assessment of affected children and lend support to liquid biopsy screening for enhanced therapeutic stratification.

Authors

Institutions

Publication Details

Journal
Genome Medicine
Published
2025-05-08
DOI
https://doi.org/10.1186/s13073-025-01482-0
Citations
7
Primary Topic
Renal and related cancers
Type
article
Field-Weighted Citation Impact
5.64

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Distinct pathways for genetic and epigenetic predisposition in familial and bilateral Wilms tumor

Susanne Gramlich, Norbert Jorch, Eva Jüttner, Sabrina Bausenwein et al.
7 citations
Genome Medicine
Renal and related cancers
5.64
article

Distinct pathways for genetic and epigenetic predisposition in familial and bilateral Wilms tumor

Susanne Gramlich, Norbert Jorch, Eva Jüttner, Sabrina Bausenwein, Markus Metzler, Carsten Friedrich, Sheena Warman, Norbert M. Graf, Barbara Ziegler, Karen Ernestus, Jörg Fuchs, Nils Welter, Kathy Pritchard‐Jones, Jana Stursberg, Rhoikos Furtwängler, Michael C. Frühwald, Jenny Wegert, Heike Streitenberger, Jochen Hubertus, Sam Behjati, Arnulf Pekrun, Selim Corbacioglu, Silke Appenzeller, Taryn D. Treger, Manfred Gessler, Birgit Fröhlich, Conor Parks, Jörg Faber, Dominik T. Schneider, Christian Vokuhl, Dietrich von Schweinitz, Ralf Knöfler
article en
7 citations

Abstract

We identified two main mechanisms of Wilms tumor predisposition: either germline genetic alterations of Wilms tumor and, less frequently, general cancer genes; or postzygotic mosaic imprinting defects activating IGF2. These findings inform future genetic screening and risk assessment of affected children and lend support to liquid biopsy screening for enhanced therapeutic stratification.

Genome MedicineVol. 17(1)
Witten/Herdecke University (DE), Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), Universität Ulm (DE), Johannes Gutenberg University Mainz (DE), University of Münster (DE), University of Cambridge (GB), University of Würzburg (DE), University Hospital Bonn (DE), University Hospitals of the Ruhr-University of Bochum (DE), University Hospital of Bern (CH), University Hospital Augsburg (DE), Cambridge University Hospitals NHS Foundation Trust (GB), Wellcome Sanger Institute (GB), University Hospital Regensburg (DE), University Medical Center of the Johannes Gutenberg University Mainz (DE), Comprehensive Cancer Center Mainfranken (DE), Evangelisches Krankenhaus Bielefeld (DE), University Hospital Schleswig-Holstein (DE), University Children's Hospital Tübingen (DE), Marien Hospital Witten (DE), Klinikum Bremen-Mitte (DE), University Hospital Carl Gustav Carus (DE), University College London (GB), University of Regensburg (DE), Ruhr University Bochum (DE), Saarland University (DE), University of Lübeck (DE)
Wellcome Trust, Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe, Julius-Maximilians-Universität Würzburg, Little Princess Trust
Good health and well-being
Openalex Percentile: Top 4%
Renal and related cancers
5.64
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.